Event Rewind – BioOhio Annual Conference Road Show Southern OhioPosted by BioOhio on Sep. 25, 2014
Trading the interstate for side streets on the way to our Annual Conference last week, we took the scenic route through Mason and Blue Ash, passing bioscience the whole way. Assurex Health, Ethicon, Life Safer, Haag-Streit USA, Prasco, and Aerpio were just some of the landmarks we passed.
The BioOhio Annual Conference Road Show in Southern Ohio, held at Cooper Creek Event Center / Blue Ash Golf Course, brought bioscience professionals together for a solid day of networking, presentations and discussion.
We want to extend special thanks to all of the organizations that came together as sponsors to make the day possible. Each sponsoring organization is active, involved and believes in the strength of Ohio’s bioscience community.
“The presenters and content were fantastic! I know we nailed it when people have their heads up, phones down and no one leaves the room, particularly considering it was a spectacular sunny day overlooking a golf course. Attendees gained valuable information and enjoyed equally valuable networking,” said John F. Lewis, Jr., President & CEO of BioOhio.
“This event was the first of three Road Show Conferences this fall. We hope to see you October 16th in Northern Ohio and November 12th in Central Ohio. Although the themes are similar, the speakers and content are different, and just as enthralling.”
Speakers focused on different stages of a company’s growth, from innovation and R&D, adapting to the changing healthcare environment, opportunities and resources in Ohio, and lessons on successful strategies to make it to market and thrive.
The first panel focused on innovation and R&D with some impassioned views on the challenges and opportunities for entrepreneurs today.
Andrew Cothrel, CEO of NovoSource, spoke about the shift in economics and how that is impacting business. “Economics are changing healthcare. Doctors must care what products cost. Clinical data is showing that new products do not necessarily produce better outcomes. Results do matter and the stage is set for price/service innovation driven by cost alignment and defendable outcomes.”
“We have a critical mass of minds in Ohio” said Daniel Miller, Medical Director at the Cincinnati Eye Institute, discussing cutting edge clinical research being performed at the Institute and around the state. He also noted that work needs to be done to allow research to move forward smoothly, particularly in the areas of patient recruitment, training/certifying staff, red tape and logistics.
BioOhio BioBulletin, September 2014Posted by BioOhio on Sep. 25, 2014
Welcome to the September BioBulletin,
This edition features Dayton area inventors. We know Wilbur and Orville Wright, but did you know James J. Ritty, owner of a tavern in Dayton, invented the cash register in 1879 to stop his patrons from pilfering house profits? The pop top can was invented in Kettering by Ermal Fraze; Barret Green invented Micro-Encapsulation; Wayne Hardy, the Goniometer, which measures location of the thalamus for surgery; Max Issacson gave us the Manually Operated External Heart Machine and Expiratory Valve; and Henry Seeler, the portable breathing resuscitator.
The first of three conferences was Sept. 18 in Blue Ash. Missed the event? Read about it here.
John Lewis, BioOhio President & CEO stated, “The presenters and content were fantastic! I know we nailed it when people have their heads up, phones down, and no one leaves the room, particularly considering it was a spectacular sunny day overlooking a golf course. Attendees gained valuable information and enjoyed equally valuable networking. I look forward to seeing you at our upcoming events this fall. Attend, learn, network, grow.”
Oct. 16 – Northern Ohio (Aurora), simultaneous with the BioOhio Regulatory Forum
Nov. 12 – Central Ohio (Grove City)
Click here for event details, including agendas, registration ($195 for members/$345 for non-members), locations and more.
BioOhio takes 2014 Annual Conference “on the road” in series of three regional eventsPosted by BioOhio on Sep. 15, 2014
Last autumn, Ohio’s bioscience industry convened its Annual Conference in its most central metropolis, Columbus. This year, however, BioOhio changes the scope of its Annual Conference by taking it “on the road.” Beginning September 18 in the Cincinnati area, BioOhio’s Annual Conference kicks-off a series of three regional meetings to reach Ohio’s bioscience members in their backyards – at the roots of Ohio’s bioscience industry.
In fact, the 2014 Annual Conference is titled, “Bioscience at its Roots: Members, Innovation, Growth” in recognition of the discoveries, commerce and connections that continue to grow the foundation of Ohio’s robust bioscience industry. “The BioOhio Board of Trustees and members who collaborated to create our Annual Conference are committed to this concept,” said John Lewis, President and CEO of BioOhio. “We find that when we travel to different corners of the state, we inevitably reach new people, discover new organizations and technologies, and learn new strategies to help us accelerate Ohio’s bioscience industry.”
The agenda for each of the three events draws heavily upon the experts and organizations native to each region in addressing region-specific concerns and opportunities. Jack Kraeutler, CEO of Cincinnati-based Meridian Bioscience, will participate in a panel on Transforming Healthcare. “We’re delighted to be involved in Ohio’s vibrant bioscience industry, and look forward to discussing opportunities and challenges that lie ahead. This event consistently offers excellent networking and enlightening content.”
BioOhio’s Annual Conference Road Show brings Ohio’s Bioscience Community TogetherPosted by BioOhio on Sep. 10, 2014
For over 25 years, BioOhio has hosted an Annual Conference, and we are excited to take this year’s around the state, with regional events in Southern, Northern and Central Ohio. The theme of the three conferences focuses on the root of bioscience, including R&D, innovation, networking, and success stories.
The 2014 Annual Conference Road Show brings together Ohio’s clinical, research, commercial, economic development and funding professionals to chart the state of “Bio in Ohio,” and chart their own role in expanding Ohio’s bioscience future.
Thank you for making our industry strong and growing. As BioOhio’s President & CEO, I take pride in seeing so many motivated, engaged and supportive members. Please keep it up, and spread the word. We have an active Board of Trustees, so be sure to meet them because, along with our members, their strategic input is invaluable.
BioOhio members have asked for more networking, education, advocacy and talent-related services, and we responded to these requests. Members drive our activities, so let us know how we can keep improving and meeting your needs!
Share your accomplishments with us so we can make those stories more visible to the world. Please also provide us with testimonials about how BioOhio has helped you.
It is your engagement, participation and commitment that makes BioOhio a vibrant, valuable resource, and Ohio a great place to do business.
If you are not already registered to attend, click here to learn more and sign up today!
Enjoy the conference.
September is national aging month: AdvaMed presents resources on the importance of treatment for cataracts, osteoarthritis and diabetesPosted by BioOhio on Sep. 09, 2014
In recognition of National Aging Month, the Advanced Medical Technology Association (AdvaMed) has released resources on the benefit and patient value of treatments aimed at three major disease areas specific to the aging population: cataracts, osteoarthritis and diabetes.
These resources can be found at http://www.lifechanginginnovation.org/get-facts.
Cataracts Key Facts:
- Cataracts affect 24.5 million Americans, and the prevalence of the disease is expected to increase significantly as the population ages. The cataract caseload is expected to rise 55 percent by 2020, and 104 percent by 2050.
- Major vision problems cost the economy $35.4 billion a year.
- Cataract surgery with intraocular lens technology – the only known treatment – improves vision and overall quality of life. Research has shown cataract surgery patients live longer; there is a 40 percent lower long-term mortality risk in those who have had the procedure.
- Cataract surgery is cost-effective and provides great value to patients and the health care system. Estimates suggest that all cataract surgeries performed over the course of a single year save more than $123 billion over the subsequent thirteen years, and deliver a 4,567 percent financial return on investment to society.
- View the full toolkit and infographic (pdf files).
Osteoarthritis Key Facts:
- Osteoarthritis (OA) is a progressive, destructive disease of the major joints for which there is no cure. It is one of the leading causes of disability and functional limitation in the U.S.
- Osteoarthritis impacts the economy by driving up employer and health costs. Bone and joint disorders, including OA, account for 440 million lost days at work and $110 billion in lost wages each year—more than any other medical condition.
- Total joint replacement helps patients return to their lives and contributes to improved general health. Patients’ physical function is shown to improve by 79 percent after total hip replacement and 56 percent after total knee replacement.
- Total knee replacement surgery generates net societal savings of approximately $19,000 per patient lifetime due to reduced disability costs and improved productivity. For all knee replacement surgeries performed in the U.S. in 2009, aggregate lifetime savings are estimated at $12 billion.
- Hip and knee implants have shown a dramatic decline in price over the past six years, at 23 percent and 17 percent, respectively.
- View the full toolkit and infographic (pdf files).
Diabetes Key Facts:
- Nearly 26 million Americans are thought to have diabetes, and if recent trends continue, as many as one in three American adults could have diabetes by 2050.
- Diabetes imposes a substantial economic burden on society and is one of the costliest chronic diseases. Diagnosed cases of diabetes cost the economy $245 billion in 2012.
- Medical technologies, like advanced diagnostics, continuous glucose monitors and insulin pumps, have revolutionized the ways in which people are screened for and live with diabetes, providing diagnostic and treatment options that contribute to improved health outcomes and a better quality of life.
- Insulin pumps alone can save individuals nearly $6,000 per year versus not using the device. Expanded investment in technology to treat diabetes will generate tremendous net economic savings over time – $225 billion over 25 years.
- View the full toolkit and infographic (pdf files).